A-CAR032
/ AbelZeta Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 16, 2026
A Phase I Trial of A-CAR032 in Participants With mCRPC
(clinicaltrials.gov)
- P1 | N=27 | Recruiting | Sponsor: Shanghai AbelZeta Ltd.
New P1 trial • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor • STEAP2
1 to 1
Of
1
Go to page
1